In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
Prestige Consumer Healthcare Inc (NYSE: PBH) closed the day trading at $80.32 up 0.59% from the previous closing price of $79.85. In other words, the price has increased by $0.59 from its previous closing price. On the day, 0.56 million shares were traded. PBH stock price reached its highest trading level at $81.65 during the session, while it also had its lowest trading level at $79.14.
Ratios:
For a better understanding of PBH, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 40.55 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 16.31. For the most recent quarter (mrq), Quick Ratio is recorded 2.82 and its Current Ratio is at 4.20. In the meantime, Its Debt-to-Equity ratio is 0.57 whereas as Long-Term Debt/Eq ratio is at 0.56.
On June 21, 2024, DA Davidson Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $65 to $93.
On November 17, 2022, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $71.Canaccord Genuity initiated its Buy rating on November 17, 2022, with a $71 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 10 ’25 when Fritz Mary Beth sold 1,678 shares for $90.00 per share. The transaction valued at 151,020 led to the insider holds 17,157 shares of the business.
Fritz Mary Beth bought 1,678 shares of PBH for $151,020 on Mar 10 ’25. On Mar 03 ’25, another insider, Fritz Mary Beth, who serves as the SVP Quality & Regulatory of the company, sold 6,297 shares for $85.39 each. As a result, the insider received 537,701 and left with 18,835 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PBH now has a Market Capitalization of 3954426624 and an Enterprise Value of 4892130304. As of this moment, Prestige’s Price-to-Earnings (P/E) ratio for their current fiscal year is 18.74, and their Forward P/E ratio for the next fiscal year is 15.99. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.97. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.49 while its Price-to-Book (P/B) ratio in mrq is 2.17. Its current Enterprise Value per Revenue stands at 4.3 whereas that against EBITDA is 12.894.
Stock Price History:
The Beta on a monthly basis for PBH is 0.43, which has changed by 0.1931076 over the last 52 weeks, in comparison to a change of 0.11937654 over the same period for the S&P500. Over the past 52 weeks, PBH has reached a high of $90.04, while it has fallen to a 52-week low of $64.94. The 50-Day Moving Average of the stock is -4.30%, while the 200-Day Moving Average is calculated to be -0.22%.
Shares Statistics:
Over the past 3-months, PBH traded about 379.80K shares per day on average, while over the past 10 days, PBH traded about 445460 shares per day. A total of 49.51M shares are outstanding, with a floating share count of 48.77M. Insiders hold about 1.31% of the company’s shares, while institutions hold 105.76% stake in the company. Shares short for PBH as of 1749772800 were 1658758 with a Short Ratio of 4.37, compared to 1747267200 on 1714758. Therefore, it implies a Short% of Shares Outstanding of 1658758 and a Short% of Float of 4.8699997.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The firm’s stock currently is rated by 4.0 analysts. The consensus estimate for the next quarter is $1.19, with high estimates of $1.22 and low estimates of $1.12.
Analysts are recommending an EPS of between $4.82 and $4.75 for the fiscal current year, implying an average EPS of $4.78. EPS for the following year is $5.04, with 7.0 analysts recommending between $5.1 and $4.99.
Revenue Estimates
5 analysts predict $260.71M in revenue for the current quarter. It ranges from a high estimate of $264.47M to a low estimate of $259.39M. As of the current estimate, Prestige Consumer Healthcare Inc’s year-ago sales were $267.14MFor the next quarter, 5 analysts are estimating revenue of $291.79M. There is a high estimate of $295.14M for the next quarter, whereas the lowest estimate is $288.57M.
A total of 7 analysts have provided revenue estimates for PBH’s current fiscal year. The highest revenue estimate was $1.16B, while the lowest revenue estimate was $1.15B, resulting in an average revenue estimate of $1.15B. In the same quarter a year ago, actual revenue was $1.14BBased on 7 analysts’ estimates, the company’s revenue will be $1.18B in the next fiscal year. The high estimate is $1.19B and the low estimate is $1.16B.
